Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 891

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

CpG DNA as a vaccine adjuvant

Open access
Bode, Christian, Zhao, Gan, Steinhagen, Folkert, Kinjo, Takeshi, Klinman, Dennis M·2011·Expert Review of Vaccines

Abstract

Synthetic oligodeoxynucleotides (ODNs) containing unmethylated CpG motifs trigger cells that express Toll-like receptor 9 (including human plasmacytoid dendritic cells and B cells) to mount an innate immune response characterized by the production of Th1 and proinflammatory cytokines. When used as vaccine adjuvants, CpG ODNs improve the function of professional antigen-presenting cells and boost the generation of humoral and cellular vaccine-specific immune responses. These effects are optimized by maintaining ODNs and vaccine in close proximity. The adjuvant properties of CpG ODNs are observed when administered either systemically or mucosally, and persist in immunocompromised hosts. Preclinical studies indicate that CpG ODNs improve the activity of vaccines targeting infectious diseases and cancer. Clinical trials demonstrate that CpG ODNs have a good safety profile and increase the immunogenicity of coadministered vaccines.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1586/erv.10.174

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 136

  1. 10.1016/j.cell.2006.02.015 · DOI · Paper page
  2. 10.1128/CMR.00046-08 · DOI · Paper page
  3. 10.1038/ni.1863 · DOI · Paper page
  4. Paul WE. Fundamental Immunology . Raven Press, New York, NY, USA (1993).
  5. Razin, 1981, Prog. Nucleic Acid Res. Mol. Biol., 25, 33, 10.1016/S0079-6603(08)60482-1 · DOI
  6. Cardon, 1994, Proc. Natl Acad. Sci. USA, 91, 3799, 10.1073/pnas.91.9.3799 · DOI · Paper page
  7. 10.4049/jimmunol.167.7.3555 · DOI · Paper page
  8. 10.1073/pnas.161293498 · DOI · Paper page
  9. 10.1016/S0065-2776(08)60790-7 · DOI · Paper page
  10. 10.1038/386336a0 · DOI · Paper page
  11. Sparwasser, 1997, Eur. J. Immunol., 27, 1671, 10.1002/eji.1830270712 · DOI · Paper page
  12. Ishii, 2002, J. Exp. Med., 196, 269, 10.1084/jem.20020773 · DOI
  13. Gursel, 2002, J. Leukoc. Biol., 71, 813, 10.1189/jlb.71.5.813 · DOI
  14. 10.4049/jimmunol.168.9.4531 · DOI
  15. 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H · DOI
  16. 10.4049/jimmunol.166.8.5000 · DOI · Paper page
  17. 10.4049/jimmunol.166.4.2372 · DOI
  18. 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U · DOI
  19. 10.1002/eji.200323813 · DOI · Paper page
  20. 10.1189/jlb.1202630 · DOI · Paper page
  21. 10.1089/oli.2009.0210 · DOI
  22. 10.1016/j.jconrel.2004.02.022 · DOI
  23. Ballas, 1996, J. Immunol., 157, 1840, 10.4049/jimmunol.157.5.1840 · DOI · Paper page
  24. 10.1038/nature03547 · DOI · Paper page
  25. 10.1084/jem.20060401 · DOI · Paper page
  26. 10.1038/nrd2059 · DOI · Paper page
  27. 10.1016/j.addr.2008.12.008 · DOI · Paper page
  28. 10.1016/j.addr.2007.12.004 · DOI · Paper page
  29. 10.1189/jlb.1008671 · DOI
  30. Klaschik, 2010, Mol. Immunol., 47, 1317, 10.1016/j.molimm.2009.11.014 · DOI
  31. 10.1073/pnas.93.7.2879 · DOI · Paper page
  32. Sun, 1998, J. Exp. Med., 188, 2335, 10.1084/jem.188.12.2335 · DOI
  33. Stacey, 1996, J. Immunol., 157, 2116, 10.4049/jimmunol.157.5.2116 · DOI · Paper page
  34. 10.1038/nm0897-849 · DOI · Paper page
  35. 10.1016/j.bbrc.2004.06.059 · DOI
  36. Yi, 1996, J. Immunol., 157, 5394, 10.4049/jimmunol.157.12.5394 · DOI · Paper page
  37. Davis, 1998, J. Immunol., 160, 870, 10.4049/jimmunol.160.2.870 · DOI · Paper page
  38. Kobayashi, 1999, Cell. Immunol., 198, 69, 10.1006/cimm.1999.1572 · DOI
  39. 10.4049/jimmunol.169.5.2368 · DOI
  40. 10.1002/eji.200535744 · DOI · Paper page
  41. 10.1016/j.immuni.2005.02.008 · DOI
  42. 10.1073/pnas.96.16.9305 · DOI · Paper page
  43. 10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q · DOI · Paper page
  44. 10.4049/jimmunol.170.9.4465 · DOI · Paper page
  45. 10.1146/annurev.immunol.20.100301.064842 · DOI · Paper page
  46. Ishii, 2003, Eur. J. Immunol., 35, 2397, 10.1002/eji.200425795 · DOI
  47. 10.1111/j.1348-0421.1994.tb01867.x · DOI
  48. 10.1016/S0264-410X(98)00151-0 · DOI · Paper page
  49. 10.1002/eji.1830270931 · DOI · Paper page
  50. 10.1084/jem.186.10.1623 · DOI · Paper page
  51. 10.4049/jimmunol.167.6.3324 · DOI
  52. 10.1080/08830180600743057 · DOI
  53. Tross, 2008, J. Immunol., 181, 5785, 10.4049/jimmunol.181.8.5785 · DOI
  54. Crompton, 2008, J. Infect. Dis., 198, 1265, 10.1086/592224 · DOI
  55. Overstreet, 2010, Eur. J. Immunol., 40, 124, 10.1002/eji.200939493 · DOI
  56. Muraoka, 2010, J. Immunol., 185, 3768, 10.4049/jimmunol.0903649 · DOI
  57. 10.4049/jimmunol.168.12.6099 · DOI
  58. Sandler, 2003, Cancer Res., 63, 394
  59. 10.1084/jem.20052433 · DOI · Paper page
  60. McCluskie, 1998, J. Immunol., 161, 4463, 10.4049/jimmunol.161.9.4463 · DOI
  61. von Hunolstein, 2001, Vaccine, 19, 3058, 10.1016/S0264-410X(01)00048-2 · DOI
  62. Kovarik, 1999, J. Immunol., 162, 1611, 10.4049/jimmunol.162.3.1611 · DOI
  63. Eastcott, 2001, Vaccine, 19, 1636, 10.1016/S0264-410X(00)00422-9 · DOI
  64. Al Mariri, 2001, Infect. Immun., 69, 4816, 10.1128/IAI.69.8.4816-4822.2001 · DOI
  65. Xie, 2005, Infect. Immun., 73, 828, 10.1128/IAI.73.2.828-833.2005 · DOI
  66. Fogg, 2007, Vaccine, 25, 2787, 10.1016/j.vaccine.2006.12.037 · DOI
  67. 10.1128/IAI.71.9.5121-5129.2003 · DOI
  68. Klinman, 2007, Microbes Infect., 9, 1478, 10.1016/j.micinf.2007.08.002 · DOI
  69. 10.1128/JVI.02013-05 · DOI
  70. 10.4049/jimmunol.166.5.3451 · DOI
  71. Huang, 2008, J. Pediatr. Gastroenterol. Nutr., 46, 262, 10.1097/MPG.0b013e318156050d · DOI
  72. 10.1016/j.vaccine.2004.08.019 · DOI
  73. Rothenfusser, 2004, Blood, 103, 2162, 10.1182/blood-2003-04-1091 · DOI
  74. 10.1067/mai.2000.107927 · DOI · Paper page
  75. 10.1097/CJI.0b013e318183af0b · DOI
  76. Mukherjee, 2007, Vaccine, 25, 1607, 10.1016/j.vaccine.2006.11.007 · DOI
  77. Miller, 1989, J. Gerontol., 44, B4, 10.1093/geronj/44.1.B4 · DOI
  78. Thoman, 1989, Adv. Immunol., 46, 221, 10.1016/S0065-2776(08)60655-0 · DOI · Paper page
  79. Qin, 2004, Cell. Mol. Immunol., 1, 148
  80. 10.1016/j.vaccine.2004.07.014 · DOI
  81. Sen, 2006, Infect. Immun., 74, 2177, 10.1128/IAI.74.4.2177-2186.2006 · DOI
  82. 10.1073/pnas.95.26.15553 · DOI · Paper page
  83. Diamant, 1993, Pediatr. Infect. Dis. J., 12, 877, 10.1097/00006454-199310000-00014 · DOI
  84. Wong, 1996, Int. J. STD AIDS, 7, 490, 10.1258/0956462961918563 · DOI
  85. 10.1182/blood.V98.10.3016 · DOI · Paper page
  86. 10.4049/jimmunol.170.9.4717 · DOI
  87. Mapletoft, 2006, Virology, 353, 316, 10.1016/j.virol.2006.06.001 · DOI
  88. Linghua, 2008, Vaccine, 26, 224, 10.1016/j.vaccine.2007.10.058 · DOI
  89. Linghua, 2007, Vet. Immunol. Immunopathol., 115, 216, 10.1016/j.vetimm.2006.10.017 · DOI
  90. 10.1006/cimm.1996.0009 · DOI · Paper page
  91. Verthelyi, 2002, J. Immunol., 168, 1659, 10.4049/jimmunol.168.4.1659 · DOI
  92. Davis, 2000, Vaccine, 18, 1920, 10.1016/S0264-410X(99)00443-0 · DOI
  93. Jones, 1999, Vaccine, 17, 3065, 10.1016/S0264-410X(99)00145-0 · DOI
  94. 10.4049/jimmunol.164.3.1617 · DOI · Paper page
  95. Verthelyi, 2004, AIDS, 18, 1003, 10.1097/00002030-200404300-00007 · DOI
  96. Klinman, 2004, Vaccine, 22, 2881, 10.1016/j.vaccine.2003.12.020 · DOI
  97. Steinhagen, 2010, Vaccine
  98. 10.1007/s10875-004-6244-3 · DOI · Paper page
  99. 10.1016/S0264-410X(03)00045-8 · DOI · Paper page
  100. 10.1371/journal.pone.0002940 · DOI
  101. Traore, 2009, Vaccine, 27, 7299, 10.1016/j.vaccine.2009.08.023 · DOI
  102. 10.1097/01.aids.0000183514.37513.d2 · DOI
  103. 10.1086/653112 · DOI
  104. 10.1172/JCI23373 · DOI · Paper page
  105. 10.1073/pnas.0703395104 · DOI · Paper page
  106. 10.1158/1078-0432.CCR-08-0526 · DOI
  107. 10.1002/ijc.24850 · DOI
  108. 10.1200/JCO.2010.28.9793 · DOI · Paper page
  109. Gilkeson, 1993, Clin. Immunol. Immunopathol., 68, 283, 10.1006/clin.1993.1129 · DOI
  110. 10.1172/JCI117793 · DOI
  111. Steinberg, 1990, Immunol. Rev., 118, 129, 10.1111/j.1600-065X.1990.tb00815.x · DOI
  112. Klinman, 1990, J. Clin. Invest., 86, 1249, 10.1172/JCI114831 · DOI
  113. Linker-Israeli, 1991, J. Immunol., 147, 117, 10.4049/jimmunol.147.1.117 · DOI · Paper page
  114. Krieg, 1995, J. Clin. Immunol., 15, 284, 10.1007/BF01541318 · DOI
  115. Yi, 1996, J. Immunol., 157, 4918, 10.4049/jimmunol.157.11.4918 · DOI
  116. Mor, 1997, Hum. Gene Ther., 8, 293, 10.1089/hum.1997.8.3-293 · DOI
  117. Katsumi, 1994, Hum. Gene Ther., 5, 1335, 10.1089/hum.1994.5.11-1335 · DOI
  118. Gilkeson, 1998, J. Immunol., 161, 3890, 10.4049/jimmunol.161.8.3890 · DOI
  119. Segal, 1997, J. Immunol., 158, 5087, 10.4049/jimmunol.158.11.5087 · DOI
  120. Segal, 2000, J. Immunol., 164, 5683, 10.4049/jimmunol.164.11.5683 · DOI
  121. Bachmaier, 1999, Science, 283, 1335, 10.1126/science.283.5406.1335 · DOI · Paper page
  122. Zeuner, 2003, Arthritis Rheum., 48, 1701, 10.1002/art.11035 · DOI
  123. 10.1038/nbt0508-484a · DOI
  124. Le, 1999, J. Rheumatol., 26, 191
  125. Allen, 1993, Thorax, 48, 580, 10.1136/thx.48.5.580 · DOI
  126. Opal, 2010, Contrib. Nephrol., 167, 14, 10.1159/000315915 · DOI · Paper page
  127. Cowdery, 1996, J. Immunol., 156, 4570, 10.4049/jimmunol.156.12.4570 · DOI · Paper page
  128. Hartmann, 1996, Mol. Med., 2, 429, 10.1007/BF03401902 · DOI
  129. Klinman, 1999, Infect. Immun., 67, 5658, 10.1128/IAI.67.11.5658-5663.1999 · DOI
  130. 10.1097/00002371-200411000-00006 · DOI
  131. 10.1016/j.vaccine.2009.10.087 · DOI
  132. 10.1016/j.vaccine.2004.01.058 · DOI
  133. 10.4049/jimmunol.175.5.3084 · DOI
  134. 10.1016/j.coi.2008.07.007 · DOI
  135. Ullrich, 2008, Cytokine Growth Factor Rev., 19, 79, 10.1016/j.cytogfr.2007.10.009 · DOI
  136. 10.1086/533467 · DOI

Cited by

See all 891

Metadata

Authors
Bode, C., Zhao, G., Steinhagen, F., Kinjo, T., & Klinman, D. M.
Venue
Expert Review of Vaccines
Published
2011-04
Volume
10
Issue
4
Pages
499-511
ISSN
  • 1476-0584 (ISSN-L)
  • 1744-8395
OpenAlex
W2110223801
Cited by
891
References
10
FWCI
18.78
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CpG DNA as a vaccine adjuvant. https://app.cochat.ai/papers/10.1586/erv.10.174
The paper
Bode, C., Zhao, G., Steinhagen, F., Kinjo, T., & Klinman, D. M. (2011). CpG DNA as a vaccine adjuvant. Expert Review of Vaccines. https://doi.org/10.1586/erv.10.174

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.